These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 15950194

  • 1. Orientation of oxazolidinones in the active site of monoamine oxidase.
    Jones TZ, Fleming P, Eyermann CJ, Gravestock MB, Ramsay RR.
    Biochem Pharmacol; 2005 Aug 01; 70(3):407-16. PubMed ID: 15950194
    [Abstract] [Full Text] [Related]

  • 2. Identification of 4-substituted 1,2,3-triazoles as novel oxazolidinone antibacterial agents with reduced activity against monoamine oxidase A.
    Reck F, Zhou F, Girardot M, Kern G, Eyermann CJ, Hales NJ, Ramsay RR, Gravestock MB.
    J Med Chem; 2005 Jan 27; 48(2):499-506. PubMed ID: 15658863
    [Abstract] [Full Text] [Related]

  • 3. Alteration in spectral properties on ligand binding reveals flexibility in monoamine oxidase.
    Ramsay RR, Jones TZ, Hynson RM.
    Med Sci Monit; 2005 Sep 27; 11(9):SR15-20. PubMed ID: 16127378
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and biological evaluation of novel 5-(hydroxamic acid)methyl oxazolidinone derivatives.
    Phillips OA, D'Silva R, Bahta TO, Sharaf LH, Udo EE, Benov L, Eric Walters D.
    Eur J Med Chem; 2015 Dec 01; 106():120-31. PubMed ID: 26536532
    [Abstract] [Full Text] [Related]

  • 5. New pyrrole inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.
    La Regina G, Silvestri R, Artico M, Lavecchia A, Novellino E, Befani O, Turini P, Agostinelli E.
    J Med Chem; 2007 Mar 08; 50(5):922-31. PubMed ID: 17256833
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. On the binding of monoamine oxidase inhibitors to some sites distinct from the MAO active site, and effects thereby elicited.
    Holt A, Berry MD, Boulton AA.
    Neurotoxicology; 2004 Jan 08; 25(1-2):251-66. PubMed ID: 14697900
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Modeling of substrate-binding region of the active site of monoamine oxidase A.
    Veselovsky AV, Medvedev AE, Tikhonova OV, Skvortsov VS, Ivanov AS.
    Biochemistry (Mosc); 2000 Aug 08; 65(8):910-6. PubMed ID: 11002183
    [Abstract] [Full Text] [Related]

  • 10. Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders.
    Binda C, Newton-Vinson P, Hubálek F, Edmondson DE, Mattevi A.
    Nat Struct Biol; 2002 Jan 08; 9(1):22-6. PubMed ID: 11753429
    [Abstract] [Full Text] [Related]

  • 11. Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives.
    Delogu G, Picciau C, Ferino G, Quezada E, Podda G, Uriarte E, Viña D.
    Eur J Med Chem; 2011 Apr 08; 46(4):1147-52. PubMed ID: 21316817
    [Abstract] [Full Text] [Related]

  • 12. Novel reversible monoamine oxidase A inhibitors: highly potent and selective 3-(1H-pyrrol-3-yl)-2-oxazolidinones.
    Valente S, Tomassi S, Tempera G, Saccoccio S, Agostinelli E, Mai A.
    J Med Chem; 2011 Dec 08; 54(23):8228-32. PubMed ID: 22017497
    [Abstract] [Full Text] [Related]

  • 13. Interactions of imidazoline ligands with the active site of purified monoamine oxidase A.
    Jones TZ, Giurato L, Guccione S, Ramsay RR.
    FEBS J; 2007 Mar 08; 274(6):1567-75. PubMed ID: 17480205
    [Abstract] [Full Text] [Related]

  • 14. Monoamine oxidases: to inhibit or not to inhibit.
    Ramsay RR, Gravestock MB.
    Mini Rev Med Chem; 2003 Mar 08; 3(2):129-36. PubMed ID: 12570845
    [Abstract] [Full Text] [Related]

  • 15. Functional role of the "aromatic cage" in human monoamine oxidase B: structures and catalytic properties of Tyr435 mutant proteins.
    Li M, Binda C, Mattevi A, Edmondson DE.
    Biochemistry; 2006 Apr 18; 45(15):4775-84. PubMed ID: 16605246
    [Abstract] [Full Text] [Related]

  • 16. Structural and mechanistic studies of arylalkylhydrazine inhibition of human monoamine oxidases A and B.
    Binda C, Wang J, Li M, Hubalek F, Mattevi A, Edmondson DE.
    Biochemistry; 2008 May 20; 47(20):5616-25. PubMed ID: 18426226
    [Abstract] [Full Text] [Related]

  • 17. Observation of two different chromophores in the resting state of monoamine oxidase B by fluorescence spectroscopy.
    Woo JC, Silverman RB.
    Biochem Biophys Res Commun; 1994 Aug 15; 202(3):1574-8. PubMed ID: 8060341
    [Abstract] [Full Text] [Related]

  • 18. Exploring the structural basis of the selective inhibition of monoamine oxidase A by dicarbonitrile aminoheterocycles: role of Asn181 and Ile335 validated by spectroscopic and computational studies.
    Juárez-Jiménez J, Mendes E, Galdeano C, Martins C, Silva DB, Marco-Contelles J, do Carmo Carreiras M, Luque FJ, Ramsay RR.
    Biochim Biophys Acta; 2014 Feb 15; 1844(2):389-97. PubMed ID: 24247011
    [Abstract] [Full Text] [Related]

  • 19. Mutation of surface cysteine 374 to alanine in monoamine oxidase A alters substrate turnover and inactivation by cyclopropylamines.
    Vintém AP, Price NT, Silverman RB, Ramsay RR.
    Bioorg Med Chem; 2005 May 16; 13(10):3487-95. PubMed ID: 15848762
    [Abstract] [Full Text] [Related]

  • 20. Sulfur-substituted alpha-alkyl phenethylamines as selective and reversible MAO-A inhibitors: biological activities, CoMFA analysis, and active site modeling.
    Gallardo-Godoy A, Fierro A, McLean TH, Castillo M, Cassels BK, Reyes-Parada M, Nichols DE.
    J Med Chem; 2005 Apr 07; 48(7):2407-19. PubMed ID: 15801832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.